PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaAll Plans · Coverage · Medical Policy · CardiologyMedium impact

Coronary Artery Brachytherapy and Other Adjuncts to Coronary Interventions (CPB 0491, reviewed 2026-07-30)

Effective date
Not stated in the notice
Identified
Aug 15, 2026

Summary

Aetna considers coronary artery brachytherapy medically necessary as adjunctive treatment during a second angioplasty or stent placement when blockage has re-occurred within the localized area of a previously placed stent (in-stent re-stenosis), in native coronary arteries or coronary artery bypass grafts. Aetna also considers intravascular shockwave lithotripsy (IVL) medically necessary for hemodynamically significant, heavily calcified coronary stenoses (for example, calcium extending over 270 degrees) where primary stenting is not possible. Coronary artery brachytherapy is considered experimental, investigational, or unproven for primary prevention of re-stenosis and all other indications outside those listed.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 4 steps
01Billing team: Bill CPT 92974 and HCPCS C7533 and Q3001 for coronary brachytherapy only when it is used as adjunctive treatment during a second angioplasty or stent placement for in-stent re-stenosis, where blockage has re-occurred within the localized area of a previously placed stent, in native coronary arteries or coronary artery bypass grafts.
02Bill CPT 92972 (percutaneous transluminal coronary lithotripsy) only for hemodynamically significant, heavily calcified coronary stenoses, such as calcium extending over 270 degrees, where primary stenting is not possible.
03Brachytherapy for primary prevention of re-stenosis and all other indications not listed in the policy is considered experimental, investigational, or unproven.
04HCPCS C1761 and C7571 are not covered for the indications listed in the policy.

Codes mentioned

92972929743351033516339799636596379C7533Q3001C1761C7571I20.0I25.3I25.42I25.9T82.855AT82.855SZ95.1Z95.5Z98.61

Original notice

Coronary Artery Brachytherapy and Other Adjuncts to Coronary Interventions (CPB 0491, reviewed 2026-07-30)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account